Fresenius Medical Care (FMS) vs Viemed Healthcare (VMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Viemed Healthcare (VMD) has outperformed Fresenius Medical Care (FMS) over the past year, gaining 27.9% versus a loss of 12.7%. Over five years, VMD leads with a +62.9% price change compared with -32.0% for FMS. Fresenius Medical Care is the larger company by market cap ($10.61 billion vs $322.8 million), about 32.9 times the size, while Viemed Healthcare is growing revenue faster (+20.5% vs -64.0%).
On valuation, Fresenius Medical Care trades at a lower forward P/E (7.8x vs 21.3x for Viemed Healthcare). Fresenius Medical Care pays a dividend yielding 7.29%, while Viemed Healthcare does not currently pay one. Fresenius Medical Care converts more of its revenue into profit, with a net margin of 22.3% versus 5.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FMS | VMD |
|---|---|---|
| Share price | $20.44 | $8.52 |
| Market cap | $10.61B | $322.85M |
| 1-day change | +1.54% | -1.05% |
| YTD return | -14.19% | +14.67% |
| 1-year return | -12.69% | +27.93% |
| 5-year return | -32.05% | +62.91% |
| P/E ratio (TTM) | 11.82 | 22.42 |
| Forward P/E | 7.77 | 21.30 |
| EPS (TTM) | $1.73 | $0.38 |
| Dividend yield | 7.29% | 0.00% |
| Annual dividend | $1.49 | $0.00 |
| Revenue (latest FY) | $4.97B | $270.28M |
| Revenue growth (YoY) | -63.98% | +20.52% |
| Net income (latest FY) | $1.11B | $14.93M |
| Gross margin | 95.33% | 57.52% |
| Operating margin | 45.39% | 8.49% |
| Net margin | 22.33% | 5.53% |
| 52-week high | $26.42 | $12.61 |
| 52-week low | $20.00 | $6.60 |
| Distance from 52-week high | -22.63% | -32.43% |
| Analyst consensus | hold | buy |
| Avg. price target upside | +7.58% | +40.85% |
| Average volume | 1.17M | 247.43K |
| Shares outstanding | 519.02M | 37.89M |
| Employees | 106,291 | 1,490 |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Fresenius Medical Care is about 32.9 times larger than Viemed Healthcare by market value ($10.61B vs $322.85M).
- VMD has outperformed FMS by 40.6 percentage points over the past year.
- Viemed Healthcare trades at a higher earnings multiple (22.4x vs 11.8x trailing P/E).
- Fresenius Medical Care offers a meaningfully higher dividend yield (7.29% vs 0.00%).
- Fresenius Medical Care is more profitable, keeping 22.3 cents of every revenue dollar as net income versus 5.5 cents for Viemed Healthcare.
- Viemed Healthcare grew revenue faster in its latest fiscal year (+20.52% vs -63.98%).
About Fresenius Medical Care
FMS stock →Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Health Care · Misc Health and Biotechnology Services · 106,291 employees
About Viemed Healthcare
VMD stock →Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Health Care · Misc Health and Biotechnology Services · 1,490 employees
FMS vs VMD FAQ
Which is bigger, Fresenius Medical Care or Viemed Healthcare?
Fresenius Medical Care (FMS) is larger, with a market capitalization of $10.61B compared with $322.85M for Viemed Healthcare (VMD).
Which stock has performed better over the past year, FMS or VMD?
VMD returned +27.93% over the past 12 months, compared with -12.69% for FMS (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, FMS or VMD?
FMS has the lower trailing P/E at 11.8, versus 22.4 for VMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Fresenius Medical Care or Viemed Healthcare?
Fresenius Medical Care pays a dividend yielding 7.29%, while Viemed Healthcare does not currently pay a regular dividend.
Are Fresenius Medical Care and Viemed Healthcare in the same industry?
Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.